2025-05-15 - Analysis Report
Okay, here's the analysis of Merck & Co Inc (MRK), incorporating all the provided data and formatted for a clear, concise report:

## Merck & Co Inc (MRK) Stock Analysis

**Merck & Co Inc** is a global pharmaceutical company focused on developing medicines and vaccines for a wide range of diseases.

### 1. Performance vs. S&P 500 (VOO)

*   **MRK Cumulative Return:** 0.0
*   **VOO Cumulative Return:** 0.0
*   **Deviation:**
    *   **Max Deviation:** 0.0
    *   **Min Deviation:** 0.0
    *   **Current Deviation:** 0.0
    *   **Relative Deviation:** 0.0

**Analysis:**

Given all deviation values are 0, it implies MRK has performed identically to the S&P 500 (VOO) over the observed period. However, because these figures are all zero, there is no relative performance or insight to be drawn from this analysis.

### Alpha, Beta Analysis

| Year       | CAGR   | MDD    | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|------|--------|
| 2015-2017  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 108.4  |
| 2016-2018  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 151.7  |
| 2017-2019  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 185.5  |
| 2018-2020  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 172.2  |
| 2019-2021  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 175.2  |
| 2020-2022  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 261.8  |
| 2021-2023  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 264.4  |
| 2022-2024  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 247.8  |
| 2023-2025  | 0.0%   | 0.0%   | 0.0%  | 1.0  | 185.5  |

**Analysis:**

*   **CAGR:** Consistent 0.0% CAGR across all periods indicates no growth over these specific three-year windows.
*   **MDD:** 0.0% Maximum Drawdown suggests no losses were experienced within these periods, which is highly unusual and might indicate a data anomaly.
*   **Alpha:** 0.0% Alpha suggests the stock did not outperform its benchmark based on the model.
*   **Beta:** A Beta of 1.0 implies that MRK's price moved in line with the market.
*   **Cap(B):** The market capitalization shows the scale of the company.

### 2. Recent Stock Price Movement

*   **Current Price:** 73.83
*   **Last Market Data:**
    *   **Price:** 73.91
    *   **Previous Close:** 76.63
    *   **Change:** -3.55
*   **Moving Averages:**
    *   **5-Day MA:** 77.4
    *   **20-Day MA:** 79.9705
    *   **60-Day MA:** 85.8565

**Analysis:**

*   The stock price has recently decreased, as indicated by the negative change in the last market data.
*   The price is below all three moving averages (5-day, 20-day, and 60-day), suggesting a **downtrend** in the short to medium term.
*   The significant change from the previous close (-3.55) suggests a sharp negative movement, possibly due to recent news or market sentiment.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.0 (Low Risk range is 0.45~0.35)
*   **RSI:** 40.877
*   **PPO:** -0.4434
*   **20-Day Relative Deviation Change:** 0.0 (Negative: Short-term Decline)
*   **Expected Return:** 0.0%

**Analysis:**

*   **MRI:** The MRI of 0.0, well outside the low-risk range, is irregular and may require clarification, it suggests that there is very little market risk, although unlikely.
*   **RSI:** The RSI of 40.88 indicates the stock is neither overbought nor oversold.
*   **PPO:** The negative PPO suggests that the short-term moving average is below the long-term moving average, confirming the downtrend.
*   **20-Day Relative Deviation Change:** The negative change suggests a short-term decline relative to a benchmark.
*   **Expected Return:** The 0.0% expected return suggests no anticipated outperformance versus the S&P 500 over the long term based on this model.

### 4. Recent News & Significant Events

*   **2025-05-13:** Major business developments, regulatory changes, or market events.
*   **2025-05-14:** Analysts discussing recent performance in the context of industry trends and global economic factors.
*   **2025-05-12:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-05-15:** Market experts highlighting both risks and opportunities.

**Analysis:**

The news snippets suggest that Merck & Co Inc (MRK) is currently experiencing significant events, including discussions around performance and volatility, making it critical for investors to monitor closely.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-05-02 | 2.01 | 15.53 B$    |
| 2024-11-06 | 1.25 | 16.66 B$    |
| 2024-08-05 | 2.15 | 16.11 B$    |
| 2024-05-03 | 1.88 | 15.78 B$    |
| 2025-05-02 | 1.88 | 15.78 B$    |

**Analysis:**

*   **Revenue:** Revenue has fluctuated, with a high of 16.66 B$ and a recent value of 15.53 B$.
*   **EPS:** EPS has varied, showing a general trend. Investors should assess whether these earnings align with expectations and industry benchmarks.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $15.53B  | 77.98%        |
| 2024-12-31 | $15.62B  | 75.50%        |
| 2024-09-30 | $16.66B  | 75.51%        |
| 2024-06-30 | $16.11B  | 76.76%        |
| 2024-03-31 | $15.78B  | 77.56%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-03-31 | $48.34B  | 10.51%  |
| 2024-12-31 | $46.31B  | 8.08%   |
| 2024-09-30 | $44.50B  | 7.09%   |
| 2024-06-30 | $43.58B  | 12.52%  |
| 2024-03-31 | $40.36B  | 11.80%  |

**Analysis:**

*   **Revenue and Profitability:** Merck maintains robust profit margins around 75-78% on revenues that have shown fluctuations.
*   **Capital and Profitability:** The company's equity has been increasing, which corresponds with a fluctuating ROE. These levels indicate strong financial health, but it's important to examine the context behind the changes.

### 7. 종합 Summary

Based on the data provided:

*   **Recent Performance:** The stock price of Merck & Co Inc (MRK) has been trending downward recently, with a notable drop in the last trading session.
*   **Technical Indicators:** The RSI and PPO suggest neither oversold nor overbought conditions, but confirm a short-term decline.
*   **Financials:** The company has strong profitability and equity, but recent changes in financials and market events call for careful observation.
*   **News:** Recent news indicates volatility and significant events impacting the stock.

**Overall:** The current data suggests a cautious approach to MRK. While the financials are generally solid, the recent price decline, coupled with news events, warrant close monitoring. The unusual MRI value and the flat performance relative to VOO need further investigation to ensure data accuracy.
